A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Lung Cancer Research Foundation
Grant: Young investigator award
National Institutes of Health
Grant: K12,CA076930-16A1
NIH
Grant: P30 CA015704
National Institutes of Health
Grant: P50 CA228944
National Institutes of Health
Grant: K08 KCA241523A
NCI NIH HHS
Grant: K12 CA076930
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: K08 CA241523
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5K12CA076930-12
Career Development in Pediatric and Medical Oncology
National Institutes of Health
Grant: 1P50CA228944-01A1
Fred Hutchinson Cancer Research Center Lung SPORE
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals